Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1969 1
1976 2
1978 2
1980 4
1981 9
1982 3
1983 7
1984 7
1985 3
1986 5
1987 1
1988 2
1989 1
1991 1
1992 2
1993 5
1994 10
1995 3
1996 2
1997 4
1998 5
1999 4
2000 7
2001 4
2002 18
2003 18
2004 10
2005 9
2006 10
2007 17
2008 18
2009 17
2010 22
2011 13
2012 28
2013 17
2014 13
2015 14
2016 10
2017 13
2018 10
2019 5
2020 2
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

345 results
Results by year
Filters applied: . Clear all
Page 1
Galectin-9 in cancer therapy.
Fujihara S, Mori H, Kobara H, Rafiq K, Niki T, Hirashima M, Masaki T. Fujihara S, et al. Among authors: hirashima m. Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):130-7. doi: 10.2174/1872214811307020006. Recent Pat Endocr Metab Immune Drug Discov. 2013. PMID: 23514536 Review.
Cancer Therapy Due to Apoptosis: Galectin-9.
Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T. Fujita K, et al. Among authors: hirashima m. Int J Mol Sci. 2017 Jan 1;18(1):74. doi: 10.3390/ijms18010074. Int J Mol Sci. 2017. PMID: 28045432 Free PMC article. Review.
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.
Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M. Chiba S, et al. Among authors: hirashima m. Nat Immunol. 2012 Sep;13(9):832-42. doi: 10.1038/ni.2376. Epub 2012 Jul 29. Nat Immunol. 2012. PMID: 22842346 Free PMC article.
[VEGF receptors].
Sano K, Hirashima M. Sano K, et al. Among authors: hirashima m. Nihon Rinsho. 2012 Nov;70 Suppl 8:31-5. Nihon Rinsho. 2012. PMID: 23513807 Review. Japanese. No abstract available.
Blood and lymphatic systems are segregated by the FLCN tumor suppressor.
Tai-Nagara I, Hasumi Y, Kusumoto D, Hasumi H, Okabe K, Ando T, Matsuzaki F, Itoh F, Saya H, Liu C, Li W, Mukouyama YS, Marston Linehan W, Liu X, Hirashima M, Suzuki Y, Funasaki S, Satou Y, Furuya M, Baba M, Kubota Y. Tai-Nagara I, et al. Among authors: hirashima m. Nat Commun. 2020 Dec 9;11(1):6314. doi: 10.1038/s41467-020-20156-6. Nat Commun. 2020. PMID: 33298956 Free PMC article.
[Galectin].
Hirashima M, Oomizu S, Arikawa T. Hirashima M, et al. Nihon Rinsho. 2010 Jul;68 Suppl 7:149-51. Nihon Rinsho. 2010. PMID: 20960765 Japanese. No abstract available.
Galectin-9 in physiological and pathological conditions.
Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T. Hirashima M, et al. Glycoconj J. 2002;19(7-9):593-600. doi: 10.1023/B:GLYC.0000014090.63206.2f. Glycoconj J. 2002. PMID: 14758084 Review.
Galectin‑9 ameliorates fulminant liver injury.
Tadokoro T, Morishita A, Sakamoto T, Fujihara S, Fujita K, Mimura S, Oura K, Nomura T, Tani J, Yoneyama H, Iwama H, Himoto T, Niki T, Hirashima M, Masaki T. Tadokoro T, et al. Among authors: hirashima m. Mol Med Rep. 2017 Jul;16(1):36-42. doi: 10.3892/mmr.2017.6606. Epub 2017 May 18. Mol Med Rep. 2017. PMID: 28534962 Free PMC article.
345 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page